USANA Health Sciences (NYSE:USNA) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of USANA Health Sciences (NYSE:USNA) from a hold rating to a sell rating in a report released on Tuesday morning, Zacks.com reports.

According to Zacks, “USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company’s three primary product lines consist of nutritional, personal care and weight management products. The company’s products are distributed primarily through a network marketing system. “

Shares of NYSE USNA opened at $89.03 on Tuesday. The stock has a market capitalization of $1.78 billion, a PE ratio of 13.43 and a beta of 0.85. The business has a fifty day moving average price of $95.83 and a two-hundred day moving average price of $98.60. USANA Health Sciences has a fifty-two week low of $72.03 and a fifty-two week high of $107.85.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 27th. The company reported $1.87 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.09. USANA Health Sciences had a return on equity of 33.65% and a net margin of 11.09%. The company had revenue of $336.84 million during the quarter, compared to analysts’ expectations of $340.20 million. As a group, equities research analysts expect that USANA Health Sciences will post 6.31 earnings per share for the current fiscal year.

In other USANA Health Sciences news, Director John Turman Fleming sold 300 shares of the company’s stock in a transaction dated Monday, August 30th. The stock was sold at an average price of $97.26, for a total value of $29,178.00. Following the completion of the transaction, the director now owns 851 shares of the company’s stock, valued at approximately $82,768.26. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Robert A. Sinnott sold 1,648 shares of the company’s stock in a transaction dated Monday, August 16th. The stock was sold at an average price of $95.04, for a total value of $156,625.92. Following the completion of the transaction, the insider now directly owns 1,648 shares of the company’s stock, valued at approximately $156,625.92. The disclosure for this sale can be found here. Insiders have sold a total of 3,435 shares of company stock valued at $331,837 in the last three months. 0.21% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Geode Capital Management LLC grew its position in shares of USANA Health Sciences by 8.4% in the 1st quarter. Geode Capital Management LLC now owns 204,309 shares of the company’s stock valued at $19,940,000 after buying an additional 15,758 shares during the last quarter. Quantbot Technologies LP grew its position in shares of USANA Health Sciences by 378.8% in the 1st quarter. Quantbot Technologies LP now owns 3,835 shares of the company’s stock valued at $374,000 after buying an additional 3,034 shares during the last quarter. Swiss National Bank grew its position in shares of USANA Health Sciences by 1.4% in the 1st quarter. Swiss National Bank now owns 28,900 shares of the company’s stock valued at $2,821,000 after buying an additional 400 shares during the last quarter. QS Investors LLC grew its position in shares of USANA Health Sciences by 35.1% in the 1st quarter. QS Investors LLC now owns 8,200 shares of the company’s stock valued at $801,000 after buying an additional 2,130 shares during the last quarter. Finally, Prudential Financial Inc. grew its position in shares of USANA Health Sciences by 11.9% in the 1st quarter. Prudential Financial Inc. now owns 132,840 shares of the company’s stock valued at $12,965,000 after buying an additional 14,104 shares during the last quarter. 54.77% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.

Featured Article: volatile stocks

Get a free copy of the Zacks research report on USANA Health Sciences (USNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.